Session ID: 
258

Pharmacogenomics Within the EHR

4:30pm - 5:30pm Thursday, March 8
Las Vegas - Venetian Convention Center
Delfino 4002

Description

The National Institutes of Health Clinical Center (NIH CC) is the largest research hospital in the United States. Patient safety and clinical quality is a major goal of the hospital. To this end, we implemented a pharmacogenomics program within the NIH CC Electronic Health Record. The program currently consists of genotyping for HLA-A and HLA-B gene variations with clinical decision support (CDS) for abacavir, carbamazepine, and allopurinol and genotyping for drug metabolizing enzymes and transporters (DMET): SLCO1B1 for CDS of simvastatin and TPMT for CDS of mercaptopurine, azathioprine, and thioguanine. This session will review the clinical, laboratory, informatics, and policy decisions involved in implementing pharmacogenomics within an EHR.

Learning Objectives: 

  • Describe the clinical, laboratory, informatics, and policy decisions involved in implementing pharmacogenomics within an EHR
  • Discuss the ordering process, clinical decision support processes involved in the pharmacogenomics of the EHR
  • Evaluate the implementation of the pharmacogenomics within an EHR

Speaker(s): 

Chief Information Officer,
NIH Clinical Center
Chief Pharmacy Information Officer,
NIH Clinical Center
Continuing Education Credits: 
ABPM
1.00
ACHE
1.00
ACPE
1.00
CAHIMS
1.00
CME
1.00
CNE
1.00
CPHIMS
1.00
PDU
1.00

Audience: 

C-Suite
Pharmacy Professional
Physician, CMO, CMIO

Level: 

Introductory

WHERE THE WORLD
CONNECTS FOR HEALTH